Invatec Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 900

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Invatec General Information

Description

Provider of vascular interventional products for the treatment of cardiovascular disease. The company offers endovascular treatment of critical limb ischemia, carotid artery stenting and provides drug eluting balloon, treating arteries in the coronary and the upper/lower leg for the purpose of maximizing the long term patency of diseased vessels.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Via Martiri della Libertà 7
  • 25030 Roncadelle
  • Italy
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Surgical Devices
Acquirer
Golden Max
Corporate Office
  • Via Martiri della Libertà 7
  • 25030 Roncadelle
  • Italy

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invatec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Invatec‘s full profile, request access.

Request a free trial

Invatec Patents

  • 259

    Total Documents Applications and Grants

  • Total Patents Families

  • 150

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Invatec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9675734-B2 Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof Active 29-Aug-2014
US-20160058915-A1 Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof Active 29-Aug-2014
EP-3193954-B1 Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof Active 29-Aug-2014
EP-3193954-A1 Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof Active 29-Aug-2014
EP-3179928-A1 Occlusion bypassing apparatus with varying flexibility Active 14-Aug-2014 A61M25/0194
To view Invatec’s complete patent history, request access »

Invatec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invatec Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Invatec‘s full profile, request access.

Request a free trial

Invatec FAQs

  • When was Invatec founded?

    Invatec was founded in 1996.

  • Where is Invatec headquartered?

    Invatec is headquartered in Roncadelle, Italy.

  • What is the size of Invatec?

    Invatec has 900 total employees.

  • What industry is Invatec in?

    Invatec’s primary industry is Medical Supplies.

  • Is Invatec a private or public company?

    Invatec is a Private company.

  • What is the current valuation of Invatec?

    The current valuation of Invatec is .

  • What is Invatec’s current revenue?

    The current revenue for Invatec is .

  • Who are Invatec’s investors?

    Medtronic has invested in Invatec.

  • When was Invatec acquired?

    Invatec was acquired on 16-Nov-2015.

  • Who acquired Invatec?

    Invatec was acquired by Golden Max.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »